Have you or your loved ones been diagnosed with advanced malignant solid neoplasm?

You may be eligible to participate in a advanced malignant solid neoplasm clinical trial.

Have you or your loved ones been diagnosed with advanced malignant solid neoplasm? You may be eligible to participate in a advanced malignant solid neoplasm clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Advanced Malignant Solid Neoplasm Clinical Trial
NCT01822522 | Phase 1 | Interventional

Have you or your loved ones been diagnosed with advanced malignant solid neoplasm?

You may be eligible to participate in a advanced malignant solid neoplasm clinical trial.

Have you or your loved ones been diagnosed with advanced malignant solid neoplasm? You may be eligible to participate in a advanced malignant solid neoplasm clinical trial.

Completed

Male & Female

18 Years +

This study has recruited 36 Participants

This phase I trial studies the side effects and best dose of cabozantinib s-malate in treating patients with solid tumors that have spread to other places in the body and usually cannot be cured or controlled with treatment and human immunodeficiency virus. Cabozantinib s-malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.